Print-friendly View
Resources for Health Professionals and Patients
| ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral- naive adults with HIV-1 infection: 48-week results | |
Attached file: |
(Russian, 9.6 kb)
748.htm
|
Link to document(s) | http://www.ncbi.nlm.nih.gov... |
Author(s): | Murphy R. L., Brun S., Hicks C., et al. |
Document type: | Abstracts |
Language: | English, Russian |
Original language of document: | English |
Publication date: | 2001 |
Primary area(s) of focus: | HIV/AIDS |
Secondary areas of focus: | Antiretroviral Therapy (ART) |
Submited by: | Victor Stanilevskiy |
Material written specifically for patients: | No |
Date of entry: | July 26, 2004 |
| To evaluate the safety and antiviral activity of different dose levels of the HIV protease inhibitor ABT-378 combined with low-dose ritonavir, plus stavudine and lamivudine in antiretroviral-naive individuals. , 1 p. | |
Overall user rating: | Not yet reviewed |
